In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

HFA Cardio Talk

Available on your favourite apps

June 2023

Exploring the journey of Heart Transplantation - where are we in 2023?
Cornelia Margineanu.jpg

Dr. Cornelia Margineanu 
Bucharest, RO


ben gal_tuvia-2016.jpg

Dr. Tuvia Ben Gal 
Petah Tikva, IL


Throughout this podcast, the expert Dr. Tuvia Ben Gal shares a wealth of knowledge, drawing from years of experience and expertise in the field regarding indications, outcomes, specific management and also, valuable practical advice.

May 2023

Insights from late breaking clinical trials from the Heart Failure Congress 2023, Prague, CZ
Antonio Cannata(1).jpeg

Dr. Antonio Cannata
London, UK


Dr. Jozine ter Maaten 
Groningen , NL


Sotiria Liori(3).jpeg

Dr. Sotiria Liori 
Athens, GR


JJ Brugts.jpg

Dr. Jasper Brugts 
Rotterdam, NL


Prof. John Cleland 
Glasgow, UK 


Dr. Ross Campbell 
Glasgow, UK 


Francesca Musella(1).jpg

Dr. Francesca Musella 
London, UK


Dr. Jeroen Dauw 
Ghent , BE


This podcast discusses the results of four late breaking clinical trials presented at the Heart Failure congress 2023 in Prague, Czech. First, dr. Brugts shares the results of the MONITOR-HF trial, an open-label, randomized trial showing that haemodynamic monitoring using a cardioMEMS device, significantly improved quality of life and reduced heart failure hospitalizations in patients with moderate-to-severe heart failure. This trial was simultaneously published in the Lancet (Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet). Second, dr. Cleland walks us through a population study from the greater Glasgow area that found that use of loop diuretics in patients without a diagnosis of heart failure was associated with poor outcomes. He consequently discusses possible explanations and clinical consequences. Third, dr. Campbell shares the results of the DAPA-RESIST trial, that found that in patients with diuretic resistance, dapagliflozin was not superior to metolazone at relieving congestion (Dapagliflozin versus metolazone in heart failure resistant to loop diuretics | European Heart Journal | Oxford Academic ( Fourth, dr. Dauw discusses the results of the ENACT-HF trial where a strategy of natriuresis guided therapy as recommended by the HF guidelines, in an open label, sequential roll-out (first 10 patients standard of care, followed by 10-30 patients in the natriuresis arm), was shown to improve natriuresis and reduced length of hospital stay. No effect on change in congestion score or in-hospital mortality was observed. The podcast is concluded with a brief discussion of some HFA Young highlights at the congress. 

April 2023

A deep dive into translational science in Heart Failure. Lessons learnt and future perspectives.
Antonio Cannata(1).jpg

Dr. Antonio Cannata
London, UK


Mauro Giacca.jpg

Prof. Mauro Giacca
London, UK

In this episode, Dr Cannata interviews Prof Giacca on the present and future perspectives of translational science in Heart Failure. A deep dive into the translational world with a view on the research of the next 30 years. 

March 2023

Shock Talk: Epidemiology, pathophysiology and contemporary management of cardiogenic shock.
Sotiria Liori(2).jpeg

Dr. Sotiria Liori 
Athens, GR


O. Chioncel.png

Prof. Ovidiu Chioncel 
Bucarest, RO


In this HFA Cardio Talk, Dr. Sotiria Liori, member of the HFA Young Committee, interviews Prof. Ovidiu Chioncel on cardiogenic shock. The podcast delves into the challenges and latest advancements in the diagnosis and management of this complex condition, providing valuable insights for clinicians and researchers. Prof. Chioncel shares his extensive knowledge on the importance of hemodynamic monitoring, the use of mechanical circulatory support devices, and other therapeutic interventions in the management of patients with cardiogenic shock. With his practical tips and tricks, Prof. Chioncel offers guidance for optimizing patient outcomes and enhancing the quality of care for this high-risk population.

February 2023

Advanced heart failure: definition, diagnostic work-up, tips and tricks - introduction to the first HFA Advanced Heart Failure course.
Mateusz Sokolski(1).JPG

Dr. Mateusz Sokolski
Wroclaw, PL


Finn Gustafsson.png

Prof. Finn Gustafsson
Copenhagen, DK


In this HFA Cardio Talk, Finn Gustafsson, Professor of Cardiology at the University of Copenhagen, director of the advanced heart failure, transplantation and mechanical circulatory support program at Rigshospitalet in Copenhagen, Denmark and member of the HFA Board is interviewed by Dr. Mateusz Sokolski, from Wroclaw Medical University in Poland, member of the HFA Young Committee. The podcast is related to the HFA Advanced Heart Failure course 2023, discussing its aims and rationale. Moreover, the podcast covers challenges of the disease and provides tips and tricks for the management of patients with advanced heart failure and long-term mechanical circulatory support.

January 2023

Diagnosis and management of myocarditis: current state and future perspectives
Emanuele Bobbio.jpg

Dr. Emanuele Bobbio
Gothenburg, SW


Carsten Tschoepe.jpg

Prof. Carsten Tschoepe
Berlin, DE


In this HFA Cardio Talk, Prof. Tschöpe, chair of the HFA Committee on "Cardiomyopathies, Myocarditis & Pericardial Disease", is interviewed by Dr. Bobbio, member of the HFA Young Committee, on myocarditis. This podcast will walk us through the diagnostic and therapeutic challenges of myocarditis, explaining the role of biomarkers, imaging techniques and histology in defining different subtypes of myocarditis and their prognostic and therapeutic implications. Prof. Tschöpe will also provide tips and tricks for the management of patients presenting with acute, fulminant forms of myocarditis.

December 2022

Emerging key role of patients profiling in heart failure patients management

Dr. Francesca Musella
Naples, IT


Dra. Brenda Moura_2.jpg

Dr. Brenda Moura
Porto, PT


In this HFA Cardio Talk, Dr. Francesca Musella interviews Dr. Brenda Moura on the emerging role of patients´profiling in Heart Failure. The podcast starts with an overview of this emerging concept introduced by current HF guidelines, and then addresses the main benefits and practical repercussions of following this approach in clinical practice. In conclusion, the podcast underlies how tailoring HF medications prescription to each patient specific profile and personal tolerability may guide physicians to both HF medications prescription and up-tritation in real world scenarios.


November 2022

Valvular heart disease in patients with heart failure
Head photo tomasoni.jpg

Dr. Daniela Tomasoni 
Brescia, IT


Head photo Adamo.jpg

Dr. Marianna Adamo
Brescia, IT


In this HFA Cardio Talk, Dr. Daniela Tomasoni interviews Dr.Marianna Adamo on valvular heart disease in heart failure. The podcast starts with an epidemiological overview and then addresses the main pathophysiological mechanisms of valvular heart disease in patients with heart failure. It also discusses current recommendations regarding the treatment of mitral regurgitation. In conclusion, dr. Adamo will guide us through the new available percutaneous devices for the treatment of tricuspid regurgitation.

October 2022

The changing role of Cardiovascular Magnetic Resonance in Heart Failure patients
Jessica Artico photo.jpg

Dr. Jessica Artico
London, UK


Chiara Bucciarelli Ducci photo.jpeg

Prof. Chiara Bucciarelli-Ducci 
London, UK


In this HFA Cardio Talk, Prof Chiara Bucciarelli-Ducci, interviewed by Dr Jessica Artico, will discuss the enhanced role of Cardiovascular Magnetic Resonance in Heart Failure Patients and in the new HF guidelines.  It will walk us through the advancements of this imaging technique, what can possibly change after the results of recent HF trials, as well as the role of stress CMR and the future perspectives of CMR for a HF specialist. 

September 2022

Lived Experiences of Dyads with a Left Ventricular Assist Device: Lessons Learned for Around the World
A. Massouh.jpg

Dr. Angela Massouh  
Beirut, Lebanon



Dr. Loreena Hill
Belfast, Ireland


In this HFA Cardio Talk, Dr. Angela Massouh interviews Dr. Loreena Hill on living with a left ventricular assist device, and lessons learned from around the globe. This podcast addresses the experiences of patients living with a left ventricular assist device and their informal caregivers. It will also highlight clinical aspects of self-care and how international multidisciplinary healthcare providers can do better to assist this vulnerable group.

July 2022

Gene Editing: Paving the way to end the burden of inherited cardiomyopathies or just a useful research tool?
Emma Robinson.jpg

Dr. Emma Louise Robinson
Aurora, Colorado, U.S



Prof. Luisa Mestroni 
Aurora, Colorado, U.S


In this HFA Cardio Talk podcast, Dr Emma Robinson interviews Prof Luisa Mestroni, Director of the International Familial Cardiomyopathy Registry and Co-Director of the Molecular Genetics Program of the Cardiovascular Institute in Denver. This podcast discusses current approaches to diagnosis, treatment options and support for patients and families of inherited cardiomyopathy as well as how advances in gene editing have transformed translational research, understanding of disease mechanisms and prospects for clinical care.

June 2022

HFpEF – The enigma of Heart Failure

Assist. Prof. Markus Wallner
Graz, Austria



Prof. Rudolf de Boer
Groningen, the Netherlands


This podcast discusses the most recent developments in heart failure with preserved ejection fraction (HFpEF). Prof. de Boer, HFA board member and HFpEF expert, is interviewed by Dr. Wallner, chair of the HFA Young Committee, and will walk us through the diagnostic and therapeutic challenges of HFpEF and provide tips and tricks for the management of patients with HFpEF.

May 2022

Insights and prospects from the Heart Failure Congress 2022, Madrid, Spain
A. Cannata.jpg

Dr. Antonio Cannata
London, UK



Dr. Mateusz Sokolski,
Wrocław, Poland



Dr. Otilia Țica
Oradea, Romania



Prof. Finn Gustafsson
Copenhagen, Denmark


John Cleland_photo.png

Prof. John Cleland
London, UK



Prof Theresa McDonagh
London, UK



Prof. Gianluigi Savarese
Stockholm, Sweden


Carolyn Lam_PIC.jpeg

Prof Carolyn Lam


Marco Metra.jpg

Prof. Marco Metra
Brescia, Italy


This podcast discusses the insights and highlights shared by key-leaders in heart failure during the annual meeting: Heart Failure Congress, held in Madrid, Spain. Prof. Gustafson offers an overview on advanced heart failure therapies and the role of MCS (mechanical circulatory support). Prof Cleland debates when should we attempt revascularisation in heart failure patients. Prof McDonagh shares the updates and changes in the implementation of the HF guidelines in the last year, since their release. Prof Savarese highlights the best scientific statement of this year, the universal definition of Heart Failure. Prof Lam provides key message and trials in HF and also underlines the sex-differences in these patients. Prof Metra discusses the pillars and future perspectives of HF and the importance of education.

April 2022

Tips and tricks in interpretation of clinical trials
Petar Seferovic.jpg

Prof. Petar M. Seferović
Belgrade, Serbia



Dr. Ivan Milinković
Belgrade, Serbia


The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment

March 2022

Implementing the use of HF treatments in clinical practice

Prof. Gianluigi Savaresse
Stockholm, Sweden


Otilia Tica.jpg

Dr. Otilia Țica
Oradea, Romania 


This podcast discusses the optimal implementation of heart failure therapies: guidelines, and challenges. It tackled how registries support implementation of care and trial design in heart failure. Prof. Gianluigi Savaresse interviewed by Dr Otilia Țica, member of HFA Young committee, will guide us throughout the challenges of implementing optimal therapies in HF and will offer an insight on how registries can help directly improve quality of care.


February 2022

The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives

Giuseppe Rosano
London, UK


A. Cannata.jpg

Dr. Antonio Cannata
London, UK


This podcast discusses the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.


January 2022

Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines

Prof. Ewa A. Jankowska
Wroclaw, Poland



Mateusz Sokolski
Wroclaw, Poland


The podcast presents the news and controversies related to 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The discussion between co-author of the guidelines and member of HFA Young Committee covers the important clinical aspects of medical treatment of heart failure and co-morbidities taking into account some doubts coming from guidelines and gaps in evidence.

The content of this podcast reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.